Blood Test Detects Early-Stage Cancers.
A blood test being developed by Grail may not only detect early-stage cancers, but also determine where those cancers originate: In an ongoing study, the methylation-based assay detected 55.1% of cancers across types and stages and correctly identified the tissue of origin in 90.2% of cases.